BOSTON (Reuters) - The U.S. Food and Drug Administration on Friday advised hospitals to stop using Hospira Inc's Symbiq infusion system, saying a security vulnerability could allow cyber attackers to take control of the system remotely.
from Reuters: Technology News http://ift.tt/1IdEPhE
No comments:
Post a Comment